Curriculum Vitae of new proposed member of the Board – Maria Koehler
Dr Maria Koehler, Ph.D., is a hematologist/oncologist with a successful academic career
and more than 20 years of experience in both large, multinational pharmaceutical and
biotechnology companies. Since late 2017, Maria has served as the Chief Medical Officer
of a private biotech company, Bicycle Therapeutics. Previously, she was the VP of
Strategy & Innovation for Pfizer Oncology, spearheading major acquisitions and strategic
portfolio decisions within the Leadership Team. Before, as the Pfizer Oncology
Integrated Development Leader, she was the brain behind the development of Ibrance, a
>$4B cancer medicine. Her professional background includes clinical work in Poland and
Germany, associate professorship at the University of Pittsburgh, experience as Director
of Bone Marrow Transplant at St. Christopher’s Hospital in Philadelphia, executive
positions at AstraZeneca, GSK and Pfizer, and postgraduate lectureship at Fudan
University, Shanghai. She received her MD and PhD from the Silesian Medical School in
Poland. She has co-authored more than 150 publications, book chapters and patents.
Her advisory roles have included scientific and strategic support for NCI, ASCO, EORTC
and Breast Cancer IMPAKT Scientific Boards, and the Breast Cancer Research
Foundation. She has served as an Advisor to multiple biotech companies in USA, Europe
and Asia as well as Venture companies. She is a member of multiple committees defining
guidelines for treatment for patients with cancer.